Leaderboards/Substance Abuse Treatment and Outcomes

Substance Abuse Treatment and Outcomes

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Dana Bryazka
University of Washington
2
Alexander S. Hatoum
Washington University in St. Louis
3
Pek Kei Im
University of Oxford
4
Chaisiri Luangsinsiri
Srinakharinwirot University
5
Mia Miller
UNSW Sydney
6
Andrea López
University of Nevada, Las Vegas
7
Dylan Pickering
The University of Sydney
8
Carrie M. Mintz
Washington University in St. Louis
9
Esi Domi
Università di Camerino
10
Tse Yang Lim
Center for Disease Dynamics, Economics & Policy

Rising Stars Papers

1
Different mechanisms underlie compulsive alcohol self-administration in male and female rats
Biology of Sex Differences|2024
22 cit.
2
Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis
The Lancet Regional Health - Americas|2024
18 cit.
3
Generalized genetic liability to substance use disorders
Journal of Clinical Investigation|2024
15 cit.
4
No‐ and low‐alcohol beer and the sponsorship of sport in <scp>Australia</scp>: <scp>An</scp> audit of sponsorship partnerships and analysis of marketing tactics
Drug and Alcohol Review|2024
12 cit.
5
Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults
The Lancet Regional Health - Western Pacific|2025
9 cit.
6
Improving Estimates of the Prevalence of Opioid Use Disorder in the United States: Revising Keyes et al
Journal of Addiction Medicine|2024
8 cit.
7
The U.S. National Academies of Science, Engineering, and Medicine Were Economical With the Truth About Alcohol and Health
Journal of Studies on Alcohol and Drugs|2025
4 cit.
8
Psychiatric genome-wide association study enrichment shows promise for future psychopharmaceutical discoveries
Communications Medicine|2025
4 cit.
9
Concerns about genetic risk testing for opioid use disorder
The Lancet Psychiatry|2024
2 cit.
10
What is the lifetime cost of alcohol consumption? an estimation of economic burden in Thailand
PLoS ONE|2025
2 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Sarah E. Wakeman
Harvard University
2
Ryan McNeil
Yale University
3
Brooke Hoots
Centers for Disease Control and Prevention
4
Seung-Hee Hong
Guideline Geo (Sweden)
5
Edwin A. Salsitz
Icahn School of Medicine at Mount Sinai
6
Laurie K. Mischley
Bastyr University
7
Desiree Mustaquim
Centers for Disease Control and Prevention
8
Ayana Jordan
New York University
9
Zachary A. Kasper
Washington University in St. Louis
10
Michelle Sexton
University of California San Diego

Emerging Leaders Papers

1
Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021
American Journal of Public Health|2022
93 cit.
2
The practice and embodiment of “goofballs”: A qualitative study exploring the co-injection of methamphetamines and opioids
International Journal of Drug Policy|2022
46 cit.
3
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder
Journal of Addiction Medicine|2023
45 cit.
4
ATP and NAD+ Deficiency in Parkinson’s Disease
Nutrients|2023
40 cit.
5
Mothers Who Use Drugs: Closing the Gaps in Harm Reduction Response Amidst the Dual Epidemics of Overdose and Violence in a Canadian Urban Setting
American Journal of Public Health|2022
38 cit.
6
Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022
Annals of Internal Medicine|2024
36 cit.
7
Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic
Journal of Substance Abuse Treatment|2022
35 cit.
8
Systemic Racism as a Determinant of Health Inequities for People With Substance Use Disorder
JAMA Psychiatry|2024
31 cit.
9
Cannabis-Involved Emergency Department Visits Among Persons Aged &lt;25 Years Before and During the COVID-19 Pandemic — United States, 2019–2022
MMWR Morbidity and Mortality Weekly Report|2023
29 cit.
10
The impact of racism on Black American mental health
The Lancet Psychiatry|2023
29 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Marcus Grant
World Health Organization
2
Bridget F. Grant
National Institutes of Health
3
Deborah S. Hasin
Columbia University Irving Medical Center
4
John Strang
King's College London
5
Mary E. Larimer
University of Washington
6
Henry R. Kranzler
University of Connecticut
7
Rudolf H. Moos
United States Department of Veterans Affairs
8
Jürgen Rehm
Centre for Addiction and Mental Health
9
Mark S. Goldman
University of California, Davis
10
Constance Weisner
University of California, San Francisco

Current Senior Leaders Papers

1
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II
Addiction|1993
13.3k cit.
2
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United States
Archives of General Psychiatry|2007
2.9k cit.
3
Prevalence and Co-occurrence of Substance Use Disorders and IndependentMood and Anxiety Disorders
Archives of General Psychiatry|2004
2.9k cit.
4
Epidemiology of<i>DSM-5</i>Alcohol Use Disorder
JAMA Psychiatry|2015
2.6k cit.
5
The role of coping responses and social resources in attenuating the stress of life events
Journal of Behavioral Medicine|1981
2k cit.
6
Epidemiology of Adult <i>DSM-5</i> Major Depressive Disorder and Its Specifiers in the United States
JAMA Psychiatry|2018
1.7k cit.
7
Epidemiology of Major Depressive Disorder
Archives of General Psychiatry|2005
1.6k cit.
8
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder
The Journal of Clinical Psychiatry|2008
1.6k cit.
9
Measuring health and disability : manual for WHO Disability Assessment Schedule : WHODAS 2.0
Virtual Defense Library (Ministerio de Defensa)|2010
1.6k cit.
10
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and <i>DSM-IV</i> Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013
JAMA Psychiatry|2017
1.4k cit.

Reagents for Substance Abuse Treatment and Outcomes

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Cas9 (S. pyogenes) (E7M1H) Rabbit Monoclonal Antibody (SignalFlex™ mFluor™ Violet 510 Conjugate)

#86451$458
View Evidence →
Cell Signaling TechnologyEvidence 66

SMARCB1/BAF47 (D8M1X) Rabbit Monoclonal Antibody

#91735$161,351
View Evidence →
Cytek Biosciences

PE Anti-Mouse CD274 (PD-L1, B7-H1) (10F.9G2)

#50-1243
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

DUSP6/MKP3 Antibody

Cited in 5 papers
#50945$317
View Evidence →
InnoCyto

Anti-mouse PD-L1 / VEGF-A Antibody

#514801
View Evidence →
Cell Signaling TechnologyEvidence 64

Bak (D4E4) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

#17316$458
View Evidence →